PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
63.43
-1.48 (-2.28%)
Nov 12, 2026, 12:38 PM EST - Market open

PTC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
508.89984.65779.71594279.83189.72
Short-Term Investments
1,619960.72373.75288.81130.87583.66
Cash & Short-Term Investments
2,1281,9451,153882.81410.71773.38
Cash Growth
24.64%68.66%30.66%114.95%-46.89%-29.93%
Receivables
238.07181.62158.55261.02155.61110.46
Inventory
109.3379.6523.1930.5821.8115.86
Prepaid Expenses
62.4758.5122.9341.62105.6654.68
Other Current Assets
-8.87.42.6--
Total Current Assets
2,5382,2741,3661,219693.79954.37
Property, Plant & Equipment
122.28135.42117.66178.99175.02130.01
Long-Term Investments
-----21
Goodwill
82.3482.3482.3482.3482.3482.34
Other Intangible Assets
443.69388.75118.79379.5705.89724.84
Other Long-Term Assets
21.6318.320.736.2548.5825.5
Total Assets
3,2082,8991,7051,8961,7061,938

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
41.5945.4917.276.0527.2723.03
Accrued Expenses
381.54314.64261.72366.26276.33251.83
Current Portion of Long-Term Debt
319.08569.63257.82194.3172.15208.83
Current Portion of Leases
14.2115.4813.361612.3710.27
Current Income Taxes Payable
-4.684.7-4.711.29
Current Unearned Revenue
1.982.045.510.81.35-
Other Current Liabilities
17.6816.4720.619.6712.0514.1
Total Current Liabilities
776.08968.43580.98603.1406.24509.35
Long-Term Debt
2,5232,0252,1091,9041,257956.59
Long-Term Leases
85.5596.5890.52114.81119.5493.67
Long-Term Deferred Tax Liabilities
---55.91102.83137.11
Other Long-Term Liabilities
14.513.722.2336.44166.64239.9
Total Liabilities
3,3993,1042,8032,7142,0531,937

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.080.080.070.07
Additional Paid-In Capital
2,7412,7482,5752,4662,3052,124
Retained Earnings
-2,935-2,964-3,647-3,284-2,657-2,098
Comprehensive Income & Other
2.5510.5-25.89-1.294.8-24.28
Shareholders' Equity
-191.21-205.31-1,098-818.56-347.091.44
Total Liabilities & Equity
3,2082,8991,7051,8961,7061,938

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,9422,7072,4712,2291,4621,269
Net Cash (Debt)
-813.72-761.69-1,318-1,346-1,051-495.99
Net Cash Growth
------
Net Cash Per Share
-9.83-8.63-17.15-17.99-14.65-7.04
Filing Date Shares Outstanding
83.5482.7778.8776.6173.8271.36
Total Common Shares Outstanding
83.5481.4777.775.7173.170.83
Working Capital
1,7621,306784.55615.53287.55445.02
Book Value Per Share
-2.29-2.52-14.13-10.81-4.750.02
Tangible Book Value
-717.24-676.41-1,299-1,280-1,135-805.74
Tangible Book Value Per Share
-8.59-8.30-16.72-16.91-15.53-11.38
Machinery
-64.459.7684.1966.6450.8
Construction In Progress
-2.83.0324.0114.359.02
Leasehold Improvements
-35.1631.5330.1728.9719.94
SEC Filings: 10-K · 10-Q